Forbion European Acquisition Corp. (NASDAQ:FRBN) announced that its shareholders approved its combination with biotech firm enGene at a special meeting held earlier today.
In connection with the meeting, FEAC’s public shareholders holding 10,379,144 Class A ordinary shares elected to redeem their shares.
The parties expect to close the business combination on or about October 31, subject to the satisfaction or waiver of the conditions with respect to the deal.
Forbion originally brought about $133 million into the deal from its trust, including $20 million in Class A shares held by its sponsor, Forbion Growth, and 166,665 shares already covered by a non-redemption agreement.
The SPAC supplemented this with a $56.9 million PIPE at $10.25 per share that drew the participation of institutional and strategic investors including BVF Partners, Omega Funds, Cowen Healthcare Investments, Investissement Québec, Vivo Capital, Northleaf Capital Partners and CTI Life Sciences.
Forbion European inked its deal with enGene earlier this year in May. Montreal-based company enGene is developing non-viral gene therapies to treat cancers and other conditions.
At the SPAC of Dawn During a week in which rare earth mining and space de-SPACs have seen major gains, another blast from the past is making serious waves in the market. EV battery developer QuantumScape (NYSE:QS) rose to a 52-week high of $13.79 yesterday and is cruising even higher in the pre-market. The company...
Cantor Equity Partners I (NASDAQ:CEPO) has entered into a definitive agreement to combine with Bitcoin Standard Treasury in a transaction that is worth about $4.8 billion. Bitcoin Standard Treasury aims to bring in capital from a number of equity instruments to build up one of the largest US-listed Bitcoin treasuries. The combined company is expected...
At the SPAC of Dawn Several de-SPACs have made market-moving announcements recently and they haven’t forgotten to cash in on them. Fresh off of announcing $500 million strategic investment and partnership with Apple (NASDAQ:AAPL), rare earth miner MP Materials (NYSE:MP) has followed that up with a $500 million public offering, netting the company a cool...
Pyrophyte Acquisition Corp. II (NYSE:PAII.U) announced the pricing of its $175 million IPO and its units are expected to begin trading on the NYSE under the symbol “PAII.U”, Thursday, July 17, 2025. The new SPAC plans to focus its search on companies within the energy sector that constitute critical links in the supply chain of the...
At the SPAC of Dawn Rare earth miner MP Materials (NYSE:MP) was one of the early winners of the 2020 SPAC boom, having picked up momentum following its 2020 deal with Fortress Value. But, the company’s news that it will become a major supplier of battery materials for Apple’s empire of electronic devices has sent...